Microarray profiling analysis uncovers common molecular mechanisms of rubella virus, human cytomegalovirus, and

X Mo1, L Xu, Q Yang

  • 1The Center for Heart Development, Key Lab of National Education Ministry, College of Life Sciences, Hunan Normal University, Changsha, Hunan China. moxiaoyang@yahoo.com.cn

Insights

Viral infections like rubella virus (RUBV), human cytomegalovirus (HCMV), and herpes simplex virus type 2 (HSV-2) may share common molecular pathways. These pathways, involving cell growth and collagen, could contribute to congenital cardiovascular diseases.

Area of Science:

  • Molecular biology
  • Virology
  • Cardiovascular research

Background:

  • Congenital cardiovascular diseases (CCDs) can arise from perinatal infections.
  • Understanding shared viral molecular mechanisms is crucial for CCD prevention.

Purpose of the Study:

  • To investigate common molecular mechanisms in ECV304 cells infected by rubella virus (RUBV), human cytomegalovirus (HCMV), and herpes simplex virus type 2 (HSV-2).
  • To identify gene expression changes and signaling pathways associated with viral infections linked to CCDs.

Main Methods:

  • Microarray analysis of 18,716 human genes in ECV304 cells infected with RUBV, HCMV, and HSV-2.
  • Differential gene expression analysis and biological process enrichment analysis.
  • Gene annotation to identify key pathways and genes involved.

Main Results:

  • 99 genes showed differential expression (80 up-regulated, 19 down-regulated).
  • 33 signaling pathways were significantly associated with the viral infections.
  • Five key biological processes (cell growth regulation, collagen fibril organization, mRNA transport, cell adhesion, cell shape regulation) and seven specific genes (CRIM1, WISP2, COL12A1, COL11A2, CNTN5, DDR1, VEGF) were identified.

Conclusions:

  • Common molecular mechanisms, including alterations in cell growth, collagen organization, and cell adhesion, are associated with RUBV, HCMV, and HSV-2 infections.
  • These findings suggest potential pathways through which these viral infections may contribute to congenital cardiovascular diseases.